SHL sinks $40M into Taiwanese device production

SHL will hire several hundred new employees in Taiwan this year and pour $40 million into expanding its production there of drug delivery-related medical devices including auto injectors, pen injectors, infusors and inhaler systems. The company notes that it has already spent $100 million over the previous 5 years with the same goal in mind, boosting capacity at several of its plants in Taiwan and elsewhere in China. What's driving the expansion? SHL cites the rapid growth of the biologic injectable market globally, which means "device suppliers are under pressure to broaden the range of services they can provide." Item

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.